Form 8-K - Current report:
SEC Accession No. 0001104659-23-073326
Filing Date
2023-06-21
Accepted
2023-06-21 16:05:27
Documents
15
Period of Report
2023-06-21
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2319306d1_8k.htm   iXBRL 8-K 39204
2 EXHIBIT 99.1 tm2319306d1_ex99-1.htm EX-99.1 25338
7 GRAPHIC tm2319306d1_ex99-1img001.jpg GRAPHIC 5725
  Complete submission text file 0001104659-23-073326.txt   308386

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vacc-20230621.xsd EX-101.SCH 3750
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vacc-20230621_def.xml EX-101.DEF 26916
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vacc-20230621_lab.xml EX-101.LAB 36969
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vacc-20230621_pre.xml EX-101.PRE 25540
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2319306d1_8k_htm.xml XML 5270
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Vaccitech plc (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40367 | Film No.: 231029833
SIC: 2834 Pharmaceutical Preparations